Abstract:OBJECTIVES(1) To investigate the levels of the serum soluble endothelial growth factor receptor-1 in women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. For more, to analyze the relativity between the levels of the serum soluble vascular growth factor receptor-1 and preeclampsia. (2) To detect the expression of the membrane-bound VEGFR-1 protein in the placenta tissue of the women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia, Then to analyze the relativity between the expression of the membrane-bound endothelial growth factor receptor-1 and preeclampsia.METHODS(1) The serum levels of sVEGFR-1 in 10 women with mild preeclampsia, 10 women with severe preeclampsia, 10 women with eclampsia, 10 women without preeclampsia were detected by the quantitative sandwich enzyme immunoassay technique. (2) Immunohistochemistry and quantitative analysis were used to detect membrane-bound VEGFR-1 contents and distribution in the placenta tissue.RESULTS(1) The results showed that the serum sVEGFR-1 levels of all preeclampsia groups were relatively higher than those of control group (P < 0.05) and that there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. (2) In placentas, the positive staining was detected predominantly in the membranes of villus syncytiotrophoblast cells, extravillous trophoblast cells, and villus endothelial cells. In fetal membranes, the positive staining was detected predominantly in amnionic endothelial cells. (3) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group. There were significant differences between membrane-bound VEGFR-1 contents of the mild preeclampsia,severe preeclampsia and eclampsia (P < 0.05). (4) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/ membrane-bound VEGFR-1) was relatively higher than that of control group (P < 0.05) and there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia (P < 0.05).CONCLUSIONS(1) The serum sVEGFR-1 levels of preeclampsia groups were relatively higher than those of control group, the VEGFR-1 may be related to preeclampsia. (2) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group, the membrane-bound VEGFR-1 may relate to preeclampsia. (3) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/membrane-bound VEGFR-1) was relatively higher than that of control group, the preeclampsia may contribute to VEGFR-1/ PLGF and sVEGFR-1/membrane-bound.

Inhibitory effects of vitamin E on expression of NF-κB and VCAM-1 in cultured human umbilical vascular endothelial cell induced by serum of pre-eclampsia

The effects of ligustrazine on activation of NF-κB and expression of VCAM-1 in cultured human umbilical vascular endothelial cell induced by sera of preeclampsia

Inhibitory effects of Vit E on the expression of NOSTRIN induced by umbilical serum of pre-eclampsia in cultured HUVEC

Effect of Serum of Preeclampsia on Apoptosis of Vascular Endothelial Cells and Expression of Cytokines

Protein kinase C-α activation induces NF-κB-dependent VCAM-1 expression in cultured human umbilical vein endothelial cells treated with sera from preeclamptic patients

Progress in Soluble Vascular Endothelial Growth Factor Receptor-1 and Preeclampsia

Effect of Pre-eclampsia Serum on Cytotrophoblast Invasive Ability and Endothelial Cell Apoptosis in a Model of Cytotrophoblast Coculture with Endothelial Cell

Effects of Nuclear Factor-Κb Decoy Oligodeoxynucleotide on the Function of Human Umbilical Artery Smooth Muscle Cells Induced by Umbilical Sera in Preeclumpsia

Effect of Vascular Endothelial Growth Factor on Pre-Eclampsia in Pregnant Rats

Effects of syncytiotrophoblast microparticles on proliferation and apoptosis of human umbilical vein endothelial cells.

Inhibitory Effects of Polymyxin B on NF-kappaB Activation and Expression of Procollagen I, III in Pre-Eclamptic Umbilical Artery Smooth Muscle Cells.

Vitamin D decreases cell death and inflammation in human umbilical vein endothelial cells and placental explants from pregnant women with preeclampsia cultured with TNF-α

Vascular Endothelial Growth Factor Attenuates N Omega-Nitro-L-Arginine Methyl Ester-Induced Preeclampsia-Like Manifestations In Rats

Decrease And Dysfunction Of Endothelial Progenitor Cells In Umbilical Cord Blood With Maternal Pre-Eclampsia

[The Relativity of Vascular Endothelium Growth Factor Receptor-1 and Preeclampsia].

Inhibitory effect of ligustrazine on the expression of NOSTRIN induced by umbilical serum of preeclampsia in cultured human umbilical vein endothelial cell.

Study Between the Defect of Endothelial Cell,the Dysfunctions of Blood Clotting with the Morbidity of Severe Pre-eclampsia

The expressions and significances of VEGF and p53 in placenta of normal pregnancy and pre-eclampsia patients

Imbalance of Serum T Helper 1- and 2-Type Cytokines in Preeclampsia and Gestational Hypertension

Expression and clinical implication of endothelial glycoprotein,vascular endothelial growth factor and its receptor 1 in preeclampsia

Effects of preeclampsia serum on activity and invasive ability of cultured cytotrophoblasts of first trimester of pregnancy